GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » Long-Term Capital Lease Obligation

StemCell Institute (TSE:7096) Long-Term Capital Lease Obligation : 円0 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute Long-Term Capital Lease Obligation?

StemCell Institute's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was 円0 Mil.

StemCell Institute's quarterly Long-Term Capital Lease Obligation increased from Dec. 2023 (円0 Mil) to Mar. 2024 (円7 Mil) but then declined from Mar. 2024 (円7 Mil) to Sep. 2024 (円0 Mil).

StemCell Institute's annual Long-Term Capital Lease Obligation increased from Mar. 2022 (円0 Mil) to Mar. 2023 (円5 Mil) and increased from Mar. 2023 (円5 Mil) to Mar. 2024 (円7 Mil).


StemCell Institute Long-Term Capital Lease Obligation Historical Data

The historical data trend for StemCell Institute's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute Long-Term Capital Lease Obligation Chart

StemCell Institute Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial - - - 4.56 6.68

StemCell Institute Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 6.68 -

StemCell Institute  (TSE:7096) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

StemCell Institute Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of StemCell Institute's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


StemCell Institute Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004
StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines